1,000
Participants
Start Date
April 30, 1995
Study Completion Date
March 31, 2001
Rifapentine
Isoniazid
New York University School of Medicine, New York
Columbia University/Presbyterian Medical Center, New York
Harlem Hospital Center, New York
Washington, D.C. VAMC, Washington D.C.
Carolinas Medical Center, Charlotte
Duke University Medical Center, Durham
Hines VA Medical Center, Hines
Chicago VA Medical Center (Lakeside), Chicago
Central Arkansas Veterans Health System, Little Rock
Thomas Street Clinic, Houston
Audi L. Murphy VA Hospital, San Antonio
Denver Department of Public Health and Hospitals, Denver
LA County/USC Medical Center, Los Angeles
University of California, San Francisco, San Francisco
Seattle King County Health Department, Seattle
Johns Hopkins University School of Medicine, Baltimore
Boston Medical Center, Boston
New Jersey Medical School, Newark
Nashville VA Medical Center, Nashville
University of North Texas Health Science Center, Fort Worth
University of British Columbia, Vancouver
University of Manitoba, Winnipeg
Montreal Chest Institute McGill University, Montreal
US Department of Veterans Affairs
FED
Centers for Disease Control and Prevention
FED